Tao Cui, He Yongqun, Arabandi Sivaram
University of Texas, Health Science Center at Houston, of Biomedical Informatics, Houston, TX USA.
Unit for Laboratory Animal Medicine, Department of Microbiology and Immunology, and Center for Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI USA.
J Biomed Semantics. 2016 Feb 25;7:6. doi: 10.1186/s13326-015-0039-8. eCollection 2016.
The "Vaccine and Drug Ontology Studies" (VDOS) international workshop series focuses on vaccine- and drug-related ontology modeling and applications. Drugs and vaccines have been critical to prevent and treat human and animal diseases. Work in both (drugs and vaccines) areas is closely related - from preclinical research and development to manufacturing, clinical trials, government approval and regulation, and post-licensure usage surveillance and monitoring. Over the last decade, tremendous efforts have been made in the biomedical ontology community to ontologically represent various areas associated with vaccines and drugs - extending existing clinical terminology systems such as SNOMED, RxNorm, NDF-RT, and MedDRA, developing new models such as the Vaccine Ontology (VO) and Ontology of Adverse Events (OAE), vernacular medical terminologies such as the Consumer Health Vocabulary (CHV). The VDOS workshop series provides a platform for discussing innovative solutions as well as the challenges in the development and applications of biomedical ontologies for representing and analyzing drugs and vaccines, their administration, host immune responses, adverse events, and other related topics. The five full-length papers included in this 2014 thematic issue focus on two main themes: (i) General vaccine/drug-related ontology development and exploration, and (ii) Interaction and network-related ontology studies.
“疫苗与药物本体研究”(VDOS)国际研讨会系列聚焦于与疫苗和药物相关的本体建模及应用。药物和疫苗对于预防和治疗人类及动物疾病至关重要。在这两个(药物和疫苗)领域的工作密切相关——从临床前研发到生产、临床试验、政府审批与监管,以及上市后使用监测。在过去十年中,生物医学本体学界付出了巨大努力,从本体层面描述与疫苗和药物相关的各个领域——扩展现有的临床术语系统,如SNOMED、RxNorm、NDF - RT和MedDRA,开发新的模型,如疫苗本体(VO)和不良事件本体(OAE),以及通俗医学术语,如消费者健康词汇(CHV)。VDOS研讨会系列提供了一个平台,用于讨论生物医学本体在表示和分析药物、疫苗、它们的给药方式、宿主免疫反应、不良事件及其他相关主题的开发与应用中的创新解决方案以及挑战。本2014年专题中的五篇全文聚焦于两个主要主题:(i)一般疫苗/药物相关本体的开发与探索,以及(ii)与相互作用和网络相关的本体研究。